Hepatitis C virus infections from a contaminated radiopharmaceutical used in myocardial perfusion studies.

Patel, Priti R; Larson, A Kirsten; Castel, Amanda D; Ganova-Raeva, Lilia M; Myers, Robert A; Roup, Brenda J; Farrell, Katherine P; Edwards, Leslie; Nainan, Omana; Krick, John P; Blythe, David; Fiore, Anthony E; Roche, Jeffrey C

Patel, Priti R; Larson, A Kirsten; Castel, Amanda D; Ganova-Raeva, Lilia M; Myers, Robert A; Roup, Brenda J; Farrell, Katherine P; Edwards, Leslie; Nainan, Omana; Krick, John P; Blythe, David; Fiore, Anthony E; Roche, Jeffrey C.

Affiliation

Patel PR; Office of Workforce and Career Development, Centers for Disease Control and Prevention, Atlanta, Ga 30333, USA. ppatel@cdc.gov

JAMA ; 296(16): 2005-11, 2006 Oct 25.

Article in En | MEDLINE | ID: mdl-17062864

Subject(s)

Blood-Borne Pathogens/isolation & purification; Drug Contamination; Hepacivirus/isolation & purification; Hepatitis C/transmission; Radiopharmaceuticals; Acute Disease; Aged; Aged, 80 and over; Ambulatory Care; Disease Outbreaks; Drug Compounding; Female; Heart/diagnostic imaging; Hepatitis C/epidemiology; Humans; Male; Maryland; Middle Aged; Nuclear Medicine Department, Hospital; Radionuclide Imaging; Technetium Tc 99m Sestamibi

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Drug Contamination / Hepatitis C / Blood-Borne Pathogens / Hepacivirus / Radiopharmaceuticals Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: JAMA Year: 2006 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links